Brandon Saft

Brandon Saft has worked in a variety of roles in the finance industry since 1995. Brandon began their career as a Senior Associate at PwC, followed by an Equity Research Analyst at Freidman Billings & Ramsey. Brandon then held the role of Financial Analyst at NVR, Inc. and Sr. Financial Analyst at Merck. In 2009, they moved to Actavis plc (now Allergan plc) as a Finance Manager - Brand. In 2011, they were promoted to Associate Director Finance at Allergan. Brandon then moved to Aspen Pharmacare in 2016 as Senior Director Finance. In 2021, they were promoted to Senior Director Finance at BioXcel Therapeutics, Inc. and is currently in the same role at Carisma Therapeutics.

Brandon Saft received an MBA in Finance from Emory University - Goizueta Business School and a BS in Accounting from Penn State University.